|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-1-11
|
|
pubmed:abstractText |
There is an 80-90% mortality rate within the first 2 months of the occurrence of a post-infarction ventricular septal defect (VSD) with medical treatment alone. The muscular VSD presents a technical problem for the surgeon. Surgical treatment was unsuccessful in two patients. They were treated successfully using the Amplatzer Septal Occluder, with improvement in their condition.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1401-7431
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
446-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10983682-Aged,
pubmed-meshheading:10983682-Angioplasty, Balloon, Coronary,
pubmed-meshheading:10983682-Aspirin,
pubmed-meshheading:10983682-Follow-Up Studies,
pubmed-meshheading:10983682-Heart Catheterization,
pubmed-meshheading:10983682-Heart Septal Defects, Ventricular,
pubmed-meshheading:10983682-Humans,
pubmed-meshheading:10983682-Magnetic Resonance Imaging,
pubmed-meshheading:10983682-Male,
pubmed-meshheading:10983682-Middle Aged,
pubmed-meshheading:10983682-Myocardial Infarction,
pubmed-meshheading:10983682-Prosthesis Implantation,
pubmed-meshheading:10983682-Tissue Plasminogen Activator,
pubmed-meshheading:10983682-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device.
|
|
pubmed:affiliation |
Department of Pediatrics, Lund University Hospital, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
